Encelto
encelto.com
Actively hiring
Plastics & Polymers
Surgical Instruments & Devices
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
ENCELTO is the first and only FDA-approved treatment for adults with idiopathic macular telangiectasia type 2 (MacTel). Please see Important Safety Information, full Prescribing Information, and Patient Information on website.
News
Proper technique helps mitigate surgical risks with Encelto
WAIKOLOA, Hawaii - In this Healio Video Perspective from Retina 2026, Roger A. Goldberg, MD, MBA, discusses Encelto for the treatment of macular telangiectasia type 2.Encelto (revakinagene taroretcel-lwey, Neurotech Pharmaceuticals) was approved for the t
Read more
Report
ENCELTO Now Available Through OCLI Vision to Address Rare Retinal Disease, Announces Spectrum Vision Partners
/PRNewswire/ -- OCLI Vision, a leading ophthalmology practice managed by Spectrum Vision Partners, made medical history on September 22, 2025, by performing...
Read more
Report
ENCELTO Now Available Through OCLI Vision to Address Rare Retinal Disease, Announces Spectrum Vision Partners
OCLI Vision, a leading ophthalmology practice managed by Spectrum Vision Partners, made medical history on September 22, 2025, by performing the first ENCELTO gene therapy procedure in the Northeast United States.
Read more
Report
ENCELTO Now Available Through OCLI Vision to Address Rare Retinal Disease, Announces Spectrum Vision Partners
Read more
Report
FDA approves ENCELTO implant to preserve sight in people with macular telangiectasia type 2
For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have been no FDA-approved (or other) treatments to slow or stop vision loss.
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.